American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Glaukos Corporation

GKOS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

GKOS historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of GKOS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
GKOS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
GKOS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GKOS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in GKOS holdings by institutional investors

Insider Trading

Quarterly net insider trading by GKOS's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $240,000 Jul 17, 2026 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $280,000 Apr 10, 2026 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $60,000 Jan 20, 2026 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $50,000 Oct 20, 2025 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $50,000 Jul 21, 2025 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $45,000 Apr 16, 2025 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $70,000 Jan 21, 2025 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $70,000 Oct 11, 2024 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
  • $70,000 Jul 15, 2024 Issue: Taxation/Internal Revenue Code
  • $20,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $20,000 Jul 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $20,000 Jan 18, 2023 Issue: Medicare/Medicaid Health Issues
  • $20,000 Oct 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $20,000 Jul 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $20,000 Apr 18, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jan 19, 2022 Issue: Medicare/Medicaid Health Issues
  • $20,000 Jan 18, 2022 Issue: None
  • $20,000 Oct 23, 2021 Issue: None
  • $30,000 Oct 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jul 22, 2021 Issue: None
  • $30,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Apr 20, 2021 Issue: HEALTH ISSUES
  • $20,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jan 20, 2021 Issue: HEALTH ISSUES
  • $20,000 Oct 20, 2020 Issue: HEALTH ISSUES
  • $20,000 Jul 20, 2020 Issue: HEALTH ISSUES
  • $20,000 Apr 20, 2020 Issue: HEALTH ISSUES
  • $20,000 Jan 23, 2020 Issue: HEALTH ISSUES
  • $50,000 Jan 21, 2020 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Oct 18, 2019 Issue: Health Issues
  • $50,000 Oct 16, 2019 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Jul 12, 2019 Issue: Health Issues
  • $50,000 Jul 09, 2019 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $50,000 Apr 17, 2019 Issue: Health Issues
  • $20,000 Apr 04, 2019 Issue: Health Issues
  • $50,000 Jan 19, 2019 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Jan 09, 2019 Issue: Health Issues
  • $50,000 Oct 19, 2018 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Oct 10, 2018 Issue: Health Issues
  • $50,000 Jul 18, 2018 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $10,000 Jul 11, 2018 Issue: Health Issues
  • $50,000 Apr 20, 2018 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Jan 20, 2018 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Oct 19, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Jul 18, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Apr 18, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Jan 16, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $10,000 Jan 20, 2016 Issue: Health Issues
  • $20,000 Oct 20, 2015 Issue: Health Issues
  • $20,000 Jul 17, 2015 Issue: Health Issues
Revolving Door

Former government officials who have lobbied for GKOS

12 former government officials from 8 congressional offices at 2 lobbying firms have lobbied for GKOS, most recently Jul 20, 2026.

  • Marsha Blackburn
    Keith Studdard House Legislative Director, Rep. Marsha Blackburn Formerly with Marsha Blackburn · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • Lamar Alexander
    John Herzog Senate Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President Formerly with Lamar Alexander · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • Mike Kelly
    John Ray House Legislative Assistant, Rep. Mike Kelly Formerly with Mike Kelly · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • John Cornyn
    Laura Kemper Senate Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services Formerly with John Cornyn · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • Lamar Alexander
    Brett Meeks Senate Deputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar Alexander Formerly with Lamar Alexander · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • Cathy McMorris Rodgers
    Kristin Fritsch House Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Senior Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Professional Staff Member House Committee on Energy and Commerce Formerly with Cathy McMorris Rodgers · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • John S. Tanner
    Beau Schuyler House Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre Formerly with John S. Tanner · THORN RUN PARTNERS · Jul 20, 2026
  • Kelsey Carlson Congress Special Assistant, National Security Council; Special Assistant, International Trade Administration, Dept of Commerce; Policy Advisor, Office of the Deputy Chief of Staff, Executive Office of the President; Confidential Assistant, Dept of Commerce Formerly Special Assistant, National Security Council; Special Assistant, International T · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Mar 12, 2026
See all 12 on the Revolving Door dashboard
Corporate Lobbying

GKOS Estimated quarterly lobbying spending

Revenue Breakdown

GKOS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
GKOS Income Statement
GKOS Balance Sheet
GKOS Cash Flow
U.S. Patents

New GKOS patent grants

  • Patent Title: Gonioscopes Aug. 11, 2026
  • Patent Title: Drug eluting ocular implant Jul. 28, 2026
  • Patent Title: Implant delivery apparatus Dec. 14, 2021
  • Patent Title: Implant delivery apparatus Nov. 10, 2020
  • Patent Title: Gonioscope Jun. 09, 2020
  • Patent Title: Implant delivery apparatus Apr. 23, 2019
  • Patent Title: Gonioscope Nov. 06, 2018
  • Patent Title: System and method for treating an ocular disorder Jun. 12, 2018
  • Patent Title: Ocular implant delivery systems Jun. 05, 2018
  • Patent Title: Uveoscleral shunt and methods for implanting same May. 08, 2018
  • Patent Title: Shunt device and method for treating ocular disorders Nov. 28, 2017
  • Patent Title: Intraocular physiological sensor Aug. 15, 2017
  • Patent Title: Devices and methods for glaucoma treatment Mar. 21, 2017
  • Patent Title: Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye Mar. 14, 2017
  • Patent Title: Ocular disorder treatment methods and systems Feb. 21, 2017
  • Patent Title: Implant delivery system and methods thereof for treating ocular disorders Feb. 07, 2017
  • Patent Title: System and method for delivering multiple ocular implants Jan. 31, 2017
  • Patent Title: Shunt device and method for treating ocular disorders Nov. 15, 2016
  • Patent Title: Ocular disorder treatment implants with multiple opening Apr. 05, 2016
  • Patent Title: Fluid infusion methods for ocular disorder treatment Dec. 29, 2015
  • Patent Title: System for delivering multiple ocular implants Nov. 03, 2015
  • Patent Title: Ocular system with anchoring implant and therapeutic agent Oct. 13, 2015
  • Patent Title: Combined treatment for cataract and glaucoma treatment Nov. 11, 2014
  • Patent Title: Ocular implant with therapeutic agent and methods thereof Aug. 26, 2014
  • Patent Title: Implant delivery device and methods thereof for treatment of ocular disorders Aug. 19, 2014
  • Patent Title: Ocular implant with anchor and methods thereof Aug. 12, 2014
  • Patent Title: Shunt device and method for treating ocular disorders Jul. 08, 2014
  • Patent Title: Fluid infusion methods for glaucoma treatment Dec. 31, 2013
  • Patent Title: Ocular implant systems Nov. 12, 2013
  • Patent Title: Uveoscleral shunt and methods for implanting same Aug. 13, 2013
  • Patent Title: Shunt device and method for treating ocular disorders Mar. 05, 2013
  • Patent Title: Ocular implant with double anchor mechanism Dec. 25, 2012
  • Patent Title: Method of delivering an implant for treating an ocular disorder Dec. 18, 2012
  • Patent Title: Ocular implant with anchor and therapeutic agent Sep. 25, 2012
  • Patent Title: Shunt device and method for treating glaucoma Apr. 10, 2012
  • Patent Title: System for treating ocular disorders and methods thereof Dec. 13, 2011
  • Patent Title: Gonioscope for improved viewing Dec. 06, 2011
  • Patent Title: Self-trephining implant and methods thereof for treatment of ocular disorders Nov. 22, 2011
  • Patent Title: Gonioscopic system including an optical element attachment Sep. 20, 2011
  • Patent Title: Gonioscopic system including an optical element attachment Sep. 20, 2011
  • Patent Title: Ocular implant with anchoring mechanism and multiple outlets Aug. 30, 2011
  • Patent Title: Combined treatment for cataract and glaucoma treatment May. 31, 2011
  • Patent Title: Implant delivery system and methods thereof for treating ocular disorders Feb. 01, 2011
  • Patent Title: Devices and methods for treatment of ocular disorders Feb. 01, 2011
  • Patent Title: Method of delivering an implant for treating an ocular disorder Jan. 11, 2011
  • Patent Title: Devices and methods for treatment of ocular disorders Jan. 11, 2011
  • Patent Title: Ocular implant delivery system and method thereof Dec. 28, 2010
  • Patent Title: Shunt device and method for treating glaucoma Dec. 14, 2010
  • Patent Title: Ocular implant with therapeutic agents and methods thereof May. 04, 2010
  • Patent Title: Implant with intraocular pressure sensor for glaucoma treatment Mar. 16, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to GKOS from public contracts

GKOS News

Recent insights relating to GKOS

CNBC Recommendations

Recent picks made for GKOS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GKOS

GKOS Analyst Ratings

GKOS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
GKOS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $GKOS stock a Buy, Sell, or Hold?

  • What is the price target for $GKOS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

GKOS Top Shareholders
Shareholder
Shares Held
GKOS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $GKOS stock?

  • Who owns the most shares of $GKOS stock?

  • What funds own $GKOS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GKOS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GKOS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About GKOS

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

  • Address Aliso Viejo, CA
  • Market Cap 9.1 billion
  • Employees 1,094
  • Industrial Classification Surgical & Medical Instruments & Apparatus

Glaukos Corporation (GKOS) Historical Stock Prices

Glaukos Corporation (GKOS) closed at $153.49 on September 23, 2026. Over the past year its adjusted close ranged from $74.67 to $189.55. Daily prices go back to June 25, 2015, 2,828 trading days in all.

  • 1 month-17.32%
  • 3 months+11.42%
  • Year to date+35.94%
  • 1 year+81.24%
  • 3 years+103.89%
  • 5 years+203.34%
  • Max+391.64%
See every congressional and insider trade on the GKOS price chart

Quiver Premium charts GKOS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 159.86 162.04 153.31 153.49 153.49 1,026,755
Sep 22, 2026 165.36 165.36 159.00 159.86 159.86 1,102,409
Sep 21, 2026 166.27 166.74 160.23 161.53 161.53 806,468
Sep 18, 2026 160.60 163.85 159.01 163.81 163.81 1,464,473
Sep 17, 2026 164.13 166.35 160.68 161.42 161.42 646,798
Sep 16, 2026 172.01 173.54 162.12 163.47 163.47 690,987
Sep 15, 2026 169.75 172.76 167.97 171.68 171.68 621,746
Sep 14, 2026 168.51 171.36 165.43 171.09 171.09 906,311
Sep 11, 2026 174.12 175.38 166.74 167.25 167.25 552,413
Sep 10, 2026 176.50 179.96 169.26 170.38 170.38 1,009,478
Sep 9, 2026 183.15 183.33 178.52 179.79 179.79 587,935
Sep 8, 2026 175.55 185.35 172.98 185.04 185.04 1,158,568
Sep 4, 2026 177.80 181.52 175.13 177.47 177.47 572,538
Sep 3, 2026 180.80 181.29 178.72 180.35 180.35 610,187
Sep 2, 2026 176.87 182.28 176.35 179.53 179.53 768,719
Sep 1, 2026 179.97 180.14 175.33 176.70 176.70 507,237
Aug 31, 2026 178.67 180.07 174.28 179.56 179.56 455,572
Aug 28, 2026 181.10 182.22 177.77 179.87 179.87 553,529
Aug 27, 2026 178.51 183.31 178.43 181.91 181.91 442,313
Aug 26, 2026 180.11 181.89 176.82 180.57 180.57 506,040
Aug 25, 2026 186.21 187.14 179.20 181.39 181.39 639,693
Aug 24, 2026 184.13 186.88 181.75 185.65 185.65 622,292
Aug 21, 2026 185.00 187.60 183.68 184.89 184.89 440,096
Aug 20, 2026 187.73 191.62 183.25 184.89 184.89 791,869
Aug 19, 2026 186.00 190.06 185.96 189.55 189.55 505,426
Aug 18, 2026 185.00 186.66 175.04 184.15 184.15 625,626
Aug 17, 2026 183.55 186.03 181.84 185.62 185.62 734,774
Aug 14, 2026 189.89 190.00 184.22 184.53 184.53 743,405
Aug 13, 2026 187.00 189.69 185.82 189.45 189.45 762,150
Aug 12, 2026 179.80 186.75 177.56 186.63 186.63 754,151
Aug 11, 2026 180.47 183.91 178.58 182.00 182.00 723,323
Aug 10, 2026 180.00 183.49 178.78 181.42 181.42 646,071
Aug 7, 2026 172.94 180.62 172.22 180.02 180.02 768,790
Aug 6, 2026 171.17 171.99 168.39 170.99 170.99 574,997
Aug 5, 2026 172.01 172.01 167.81 170.93 170.93 705,742
Aug 4, 2026 171.75 172.91 167.64 170.53 170.53 799,737
Aug 3, 2026 168.66 173.98 168.60 170.87 170.87 1,108,936
Jul 31, 2026 166.58 171.54 165.37 166.72 166.72 1,032,220
Jul 30, 2026 180.22 184.00 165.78 168.52 168.52 2,559,596
Jul 29, 2026 149.71 166.00 145.78 161.66 161.66 3,137,806
Jul 28, 2026 153.62 154.98 146.03 151.33 151.33 1,144,674
Jul 27, 2026 155.54 156.15 148.02 151.91 151.91 727,532
Jul 24, 2026 154.41 155.59 151.00 153.58 153.58 379,549
Jul 23, 2026 150.46 152.93 150.46 152.13 152.13 420,733
Jul 22, 2026 152.33 153.00 150.01 152.86 152.86 577,611
Jul 21, 2026 154.82 158.18 152.83 153.09 153.09 476,812
Jul 20, 2026 156.46 158.22 155.12 155.46 155.46 402,917
Jul 17, 2026 153.21 157.76 152.06 156.83 156.83 375,760
Jul 16, 2026 157.73 161.53 155.06 155.39 155.39 705,756
Jul 15, 2026 151.45 157.71 150.51 156.84 156.84 630,560
Jul 14, 2026 151.13 153.95 146.72 152.45 152.45 517,354
Jul 13, 2026 153.00 155.13 151.00 152.72 152.72 442,231
Jul 10, 2026 154.05 156.60 143.11 152.72 152.72 672,327
Jul 9, 2026 153.29 155.70 152.16 155.07 155.07 781,020
Jul 8, 2026 151.39 154.61 149.45 152.96 152.96 1,058,780
Jul 7, 2026 148.53 151.47 146.47 150.65 150.65 710,265
Jul 6, 2026 150.00 150.26 146.69 148.70 148.70 712,964
Jul 2, 2026 137.57 148.62 136.18 148.34 148.34 1,241,013
Jul 1, 2026 139.06 141.40 136.22 137.57 137.57 707,698
Jun 30, 2026 141.43 141.74 136.18 139.76 139.76 1,086,135
Jun 29, 2026 143.51 143.70 139.86 142.19 142.19 1,244,186
Jun 26, 2026 142.57 145.00 140.91 144.42 144.42 1,989,558
Jun 25, 2026 139.60 145.39 137.52 142.57 142.57 787,691
Jun 24, 2026 133.07 140.77 133.02 137.76 137.76 761,433
Jun 23, 2026 131.69 135.23 131.25 134.65 134.65 546,299
Jun 22, 2026 130.00 131.84 128.48 131.19 131.19 806,569
Jun 18, 2026 128.97 131.73 125.43 130.68 130.68 984,179
Jun 17, 2026 128.64 131.78 126.67 127.41 127.41 1,040,930
Jun 16, 2026 130.68 132.24 127.09 127.53 127.53 724,523
Jun 15, 2026 128.58 130.67 127.83 130.14 130.14 801,979
Jun 12, 2026 124.97 128.27 122.69 126.81 126.81 707,981
Jun 11, 2026 125.08 127.29 123.00 124.26 124.26 629,397
Jun 10, 2026 122.00 125.96 119.66 122.49 122.49 1,542,234
Jun 9, 2026 123.79 129.00 123.58 126.34 126.34 1,082,314
Jun 8, 2026 124.18 126.23 121.83 121.96 121.96 962,157
Jun 5, 2026 122.67 128.05 120.61 125.00 125.00 1,444,705
Jun 4, 2026 114.19 123.44 113.13 121.69 121.69 1,584,247
Jun 3, 2026 108.76 115.47 108.76 113.64 113.64 1,095,271
Jun 2, 2026 101.77 113.09 100.26 110.78 110.78 1,866,968
Jun 1, 2026 103.51 105.05 99.48 103.12 103.12 1,431,293
May 29, 2026 106.57 108.42 101.47 103.35 103.35 1,708,764
May 28, 2026 108.30 111.05 105.92 106.52 106.52 1,563,945
May 27, 2026 114.09 114.51 109.27 109.88 109.88 1,231,642
May 26, 2026 119.71 120.55 106.24 114.97 114.97 2,705,971
May 22, 2026 139.14 139.43 118.64 120.23 120.23 2,709,884
May 21, 2026 140.64 140.64 133.62 139.03 139.03 1,308,956
May 20, 2026 140.95 146.71 137.83 143.82 143.82 951,704
May 19, 2026 141.32 142.85 137.32 139.90 139.90 728,869
May 18, 2026 144.99 148.11 141.52 142.18 142.18 814,310
May 15, 2026 142.27 144.16 140.91 144.01 144.01 978,749
May 14, 2026 137.73 142.20 136.34 142.15 142.15 536,356
May 13, 2026 135.18 138.34 133.22 137.29 137.29 490,229
May 12, 2026 135.10 137.20 133.11 136.36 136.36 667,105
May 11, 2026 132.36 136.26 130.64 135.37 135.37 814,293
May 8, 2026 135.12 135.25 130.04 133.52 133.52 454,477
May 7, 2026 136.35 137.34 132.12 134.15 134.15 549,156
May 6, 2026 133.69 136.41 131.35 135.27 135.27 889,289
May 5, 2026 137.10 137.87 131.94 133.42 133.42 888,359
May 4, 2026 139.68 141.22 134.74 135.85 135.85 942,764
May 1, 2026 143.54 146.75 140.22 140.22 140.22 1,317,367
Apr 30, 2026 141.50 145.50 130.90 143.67 143.67 2,674,243
Apr 29, 2026 117.84 120.07 113.00 116.96 116.96 1,164,271
Apr 28, 2026 122.21 123.05 118.70 119.63 119.63 494,504
Apr 27, 2026 121.57 124.38 120.82 122.07 122.07 802,376
Apr 24, 2026 121.10 122.28 119.03 121.48 121.48 455,022
Apr 23, 2026 121.25 123.20 119.83 120.87 120.87 473,875
Apr 22, 2026 123.50 126.39 120.64 121.65 121.65 459,706
Apr 21, 2026 123.98 125.30 121.17 122.11 122.11 496,806
Apr 20, 2026 123.78 127.00 122.53 124.55 124.55 442,187
Apr 17, 2026 123.80 127.00 123.41 124.79 124.79 585,704
Apr 16, 2026 121.13 123.39 120.41 121.62 121.62 793,519
Apr 15, 2026 121.02 122.00 118.57 121.00 121.00 491,763
Apr 14, 2026 119.50 122.00 119.50 120.52 120.52 579,118
Apr 13, 2026 116.33 119.67 116.00 119.49 119.49 543,383
Apr 10, 2026 120.67 120.96 116.09 116.40 116.40 522,054
Apr 9, 2026 118.28 120.67 115.28 119.45 119.45 536,001
Apr 8, 2026 119.85 123.01 117.44 118.62 118.62 799,013
Apr 7, 2026 115.01 117.47 113.25 115.06 115.06 707,039
Apr 6, 2026 112.26 116.81 110.50 116.69 116.69 846,016
Apr 2, 2026 109.79 113.89 108.72 112.77 112.77 591,427
Apr 1, 2026 108.69 113.66 107.68 112.64 112.64 1,000,414
Mar 31, 2026 106.75 108.90 104.78 107.66 107.66 627,562
Mar 30, 2026 103.49 105.47 102.12 105.01 105.01 607,992
Mar 27, 2026 106.74 106.74 102.12 103.18 103.18 625,325
Mar 26, 2026 108.51 110.13 107.31 107.75 107.75 885,505
Mar 25, 2026 106.46 109.67 105.39 109.60 109.60 706,196
Mar 24, 2026 105.24 107.17 103.69 105.23 105.23 781,870
Mar 23, 2026 104.13 107.84 102.23 106.84 106.84 1,085,909
Mar 20, 2026 104.52 105.36 100.15 100.99 100.99 1,143,660
Mar 19, 2026 102.99 104.55 100.46 102.09 102.09 603,077
Mar 18, 2026 101.70 104.64 101.28 103.22 103.22 562,191
Mar 17, 2026 99.15 103.08 98.92 102.93 102.93 816,077
Mar 16, 2026 97.99 99.54 96.47 98.94 98.94 476,988
Mar 13, 2026 98.43 100.73 95.87 97.02 97.02 646,412
Mar 12, 2026 100.75 101.91 97.14 97.79 97.79 866,909
Mar 11, 2026 102.78 104.14 100.47 102.86 102.86 508,164
Mar 10, 2026 105.81 106.78 102.30 103.15 103.15 875,043
Mar 9, 2026 105.83 106.22 99.84 105.78 105.78 952,958
Mar 6, 2026 110.00 110.02 106.50 107.73 107.73 622,729
Mar 5, 2026 113.28 114.40 111.40 112.10 112.10 436,765
Mar 4, 2026 117.19 117.74 114.84 115.37 115.37 301,904
Mar 3, 2026 118.52 118.52 112.66 117.75 117.75 589,484
Mar 2, 2026 119.04 121.27 116.95 121.12 121.12 1,171,415
Feb 27, 2026 119.69 121.03 118.43 120.40 120.40 614,602
Feb 26, 2026 122.00 123.16 120.70 121.43 121.43 637,647
Feb 25, 2026 120.10 121.72 117.96 120.89 120.89 797,548
Feb 24, 2026 121.26 122.48 118.77 119.17 119.17 540,652
Feb 23, 2026 119.12 120.74 118.22 120.41 120.41 665,667
Feb 20, 2026 116.33 120.80 116.30 120.27 120.27 756,219
Feb 19, 2026 119.47 120.19 114.90 117.10 117.10 1,128,638
Feb 18, 2026 103.55 121.69 103.55 121.00 121.00 1,789,645
Feb 17, 2026 109.73 111.78 106.58 106.64 106.64 1,263,524
Feb 13, 2026 107.59 110.62 106.75 109.47 109.47 606,818
Feb 12, 2026 108.87 109.34 105.37 106.74 106.74 498,146
Feb 11, 2026 114.99 114.99 106.43 109.03 109.03 869,194
Feb 10, 2026 113.42 115.19 112.64 113.03 113.03 435,297
Feb 9, 2026 112.63 113.51 110.39 113.27 113.27 538,820
Feb 6, 2026 114.37 114.97 110.65 112.52 112.52 951,657
Feb 5, 2026 114.90 116.75 112.67 113.52 113.52 787,388
Feb 4, 2026 117.95 118.10 110.72 114.67 114.67 930,111
Feb 3, 2026 118.52 119.57 116.40 118.14 118.14 501,592
Feb 2, 2026 119.64 121.74 117.41 117.47 117.47 530,479
Jan 30, 2026 120.14 123.54 116.63 119.38 119.38 761,121
Jan 29, 2026 123.94 123.94 118.67 119.07 119.07 753,073
Jan 28, 2026 122.10 128.84 121.85 123.94 123.94 1,063,232
Jan 27, 2026 123.57 124.00 116.73 118.70 118.70 793,151
Jan 26, 2026 121.45 124.39 118.55 124.27 124.27 872,424
Jan 23, 2026 124.95 125.04 119.86 119.98 119.98 792,018
Jan 22, 2026 126.98 130.23 125.05 125.90 125.90 1,437,302
Jan 21, 2026 121.31 124.83 119.69 124.16 124.16 910,211
Jan 20, 2026 118.57 124.44 118.26 123.45 123.45 1,231,838
Jan 16, 2026 114.57 121.63 113.97 120.24 120.24 1,467,760
Jan 15, 2026 104.56 114.67 103.11 114.48 114.48 1,356,765
Jan 14, 2026 94.81 105.10 93.96 104.43 104.43 2,222,119
Jan 13, 2026 110.70 111.53 108.71 110.23 110.23 691,583
Jan 12, 2026 112.11 112.11 109.24 110.91 110.91 293,707
Jan 9, 2026 113.90 114.77 110.71 112.92 112.92 575,942
Jan 8, 2026 112.40 115.00 111.97 114.15 114.15 625,732
Jan 7, 2026 112.63 114.56 112.55 113.73 113.73 388,041
Jan 6, 2026 111.38 113.81 109.07 112.28 112.28 718,641
Jan 5, 2026 110.71 113.97 110.71 112.51 112.51 487,895
Jan 2, 2026 114.47 114.47 110.46 110.72 110.72 517,287
Dec 31, 2025 114.14 114.62 112.63 112.91 112.91 341,602
Dec 30, 2025 115.34 115.89 114.05 114.24 114.24 359,633
Dec 29, 2025 116.09 116.78 115.00 115.55 115.55 309,912
Dec 26, 2025 116.11 116.80 115.22 116.21 116.21 255,847
Dec 24, 2025 116.38 117.94 116.20 116.64 116.64 200,131
Dec 23, 2025 116.83 117.13 115.07 116.18 116.18 378,390
Dec 22, 2025 117.22 118.17 115.21 117.09 117.09 601,976
Dec 19, 2025 113.26 116.38 112.67 116.22 116.22 1,150,201
Dec 18, 2025 114.32 116.72 113.11 113.21 113.21 739,458
Dec 17, 2025 113.57 115.82 111.81 112.42 112.42 871,516
Dec 16, 2025 111.56 114.81 111.09 113.76 113.76 1,188,017
Dec 15, 2025 109.93 112.64 109.33 111.73 111.73 1,466,139
Dec 12, 2025 108.96 110.37 108.45 108.88 108.88 477,183
Dec 11, 2025 109.20 110.87 108.16 109.23 109.23 787,728
Dec 10, 2025 106.71 109.38 105.88 108.72 108.72 1,023,785
Dec 9, 2025 108.96 110.02 106.52 106.87 106.87 737,959
Dec 8, 2025 109.45 109.74 107.28 108.46 108.46 642,434
Dec 5, 2025 109.17 112.00 107.65 108.51 108.51 467,756
Dec 4, 2025 107.52 110.02 107.30 108.85 108.85 702,043
Dec 3, 2025 106.50 109.31 106.03 107.46 107.46 763,065
Dec 2, 2025 106.25 107.83 104.84 106.07 106.07 655,849
Dec 1, 2025 105.29 106.61 104.11 106.11 106.11 570,248
Nov 28, 2025 105.00 107.18 104.83 106.29 106.29 244,165
Nov 26, 2025 103.23 107.00 103.18 105.39 105.39 1,075,607
Nov 25, 2025 98.67 106.04 98.67 104.35 104.35 1,340,422
Nov 24, 2025 98.71 100.34 96.35 98.06 98.06 1,129,170
Nov 21, 2025 94.94 99.73 93.78 99.62 99.62 1,286,135
Nov 20, 2025 97.20 98.45 95.05 95.20 95.20 790,584
Nov 19, 2025 92.00 97.79 91.83 96.49 96.49 1,524,307
Nov 18, 2025 88.20 92.49 87.32 91.64 91.64 889,594
Nov 17, 2025 89.51 92.60 88.28 88.40 88.40 984,500
Nov 14, 2025 90.65 93.14 88.75 90.03 90.03 1,131,063
Nov 13, 2025 91.17 97.22 91.17 91.81 91.81 2,607,520
Nov 12, 2025 90.87 93.00 88.60 92.61 92.61 1,679,720
Nov 11, 2025 88.82 92.14 88.72 89.89 89.89 1,530,391
Nov 10, 2025 83.78 88.61 83.78 88.35 88.35 1,140,707
Nov 7, 2025 81.80 84.36 80.91 83.86 83.86 988,285
Nov 6, 2025 83.95 84.08 81.61 81.79 81.79 597,606
Nov 5, 2025 85.25 86.82 83.36 84.35 84.35 691,823
Nov 4, 2025 85.86 88.29 85.16 85.95 85.95 767,468
Nov 3, 2025 88.09 88.67 83.46 87.39 87.39 1,373,861
Oct 31, 2025 86.53 90.61 85.86 88.07 88.07 1,634,380
Oct 30, 2025 95.07 102.80 85.85 87.80 87.80 4,834,361
Oct 29, 2025 77.07 81.00 76.88 77.09 77.09 2,372,113
Oct 28, 2025 75.00 77.83 73.16 77.79 77.79 1,468,680
Oct 27, 2025 79.50 79.50 74.51 75.68 75.68 2,699,433
Oct 24, 2025 75.80 76.08 74.55 74.67 74.67 1,309,090
Oct 23, 2025 76.21 77.07 75.01 75.26 75.26 883,868
Oct 22, 2025 76.99 76.99 74.44 76.63 76.63 1,689,721
Oct 21, 2025 79.51 79.73 73.73 75.88 75.88 3,138,694
Oct 20, 2025 88.80 89.75 75.36 79.47 79.47 3,190,270
Oct 17, 2025 84.79 88.94 84.79 87.17 87.17 707,713
Oct 16, 2025 85.89 87.48 84.54 85.33 85.33 749,269
Oct 15, 2025 85.74 86.37 83.35 85.60 85.60 754,017
Oct 14, 2025 83.22 86.74 82.46 85.32 85.32 1,121,026
Oct 13, 2025 83.58 84.70 82.19 83.09 83.09 719,088
Oct 10, 2025 87.00 87.00 82.37 82.56 82.56 703,691
Oct 9, 2025 87.59 87.83 86.18 87.02 87.02 354,166
Oct 8, 2025 86.40 87.66 84.59 87.59 87.59 410,002
Oct 7, 2025 86.66 86.90 83.77 84.09 84.09 465,124
Oct 6, 2025 88.27 89.29 85.60 86.62 86.62 967,110
Oct 3, 2025 84.56 88.50 83.88 87.41 87.41 882,896
Oct 2, 2025 83.45 85.12 83.00 84.49 84.49 817,726
Oct 1, 2025 82.86 84.48 80.20 83.19 83.19 790,279
Sep 30, 2025 80.83 81.68 79.66 81.55 81.55 770,912
Sep 29, 2025 80.56 81.61 79.02 81.28 81.28 575,042
Sep 26, 2025 81.43 82.14 79.35 79.92 79.92 1,194,870
Sep 25, 2025 82.28 82.51 80.89 81.47 81.47 542,397
Sep 24, 2025 84.69 85.16 82.71 82.79 82.79 497,687
Sep 23, 2025 84.79 85.58 84.06 84.69 84.69 765,151

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Glaukos Corporation Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at GKOS, per a recent SEC DEF 14A filing. We estimate that the median employee at GLAUKOS Corp is paid $173,127.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation